These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16531525)

  • 1. Crohn's disease: why the disparity in mortality?
    Loftus EV
    Gut; 2006 Apr; 55(4):447-9. PubMed ID: 16531525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends of mortality from Crohn's disease and ulcerative colitis.
    Sonnenberg A
    Int J Epidemiol; 2007 Aug; 36(4):890-9. PubMed ID: 17420164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
    Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Chen DM; Pritchard ML; Sandborn WJ
    Clin Gastroenterol Hepatol; 2006 May; 4(5):621-30. PubMed ID: 16678077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcotic use in patients with Crohn's disease.
    Koch TR; Morowitz DA
    Am J Gastroenterol; 2006 Jun; 101(6):1397; author reply 1397-8. PubMed ID: 16771970
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recurrence of Crohn's disease after surgery--causes and risks].
    Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
    Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper gastrointestinal involvement in pediatric Crohn's disease.
    El-Matary W
    Gastroenterology; 2009 Jun; 136(7):2408-9; author reply 2409-10. PubMed ID: 19406137
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of results of surgical treatment in Crohn's disease.
    Bednarz W; Czopnik P; Wojtczak B; Olewiński R; Domosławski P; Spodzieja J
    Hepatogastroenterology; 2008; 55(84):998-1001. PubMed ID: 18705315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease, peptic ulcer and diverticular disease as certified causes of death in an English population 1979-2003.
    Goldacre MJ; Duncan M; Cook-Mozaffari P; Griffith M; Travis S
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):96-103. PubMed ID: 18188028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis in Crohn's disease: An epidemiological study of patients diagnosed more than 20 years ago in Cardiff.
    Canavan C; Abrams KR; Hawthorne B; Mayberry JF
    Aliment Pharmacol Ther; 2007 Jan; 25(1):59-65. PubMed ID: 17229220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
    Cullen G; Keegan D; Mulcahy HE; O'Donoghue DP
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: mortality in Crohn's disease.
    Canavan C; Abrams KR; Mayberry JF
    Aliment Pharmacol Ther; 2007 Apr; 25(8):861-70. PubMed ID: 17402989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.
    Tremaine WJ; Timmons LJ; Loftus EV; Pardi DS; Sandborn WJ; Harmsen WS; Thapa P; Zinsmeister AR
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1435-41. PubMed ID: 17539983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
    Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
    Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.
    Aldhous MC; Drummond HE; Anderson N; Smith LA; Arnott ID; Satsangi J
    Am J Gastroenterol; 2007 Mar; 102(3):577-88. PubMed ID: 17338736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.
    Alves A; Panis Y; Bouhnik Y; Pocard M; Vicaut E; Valleur P
    Dis Colon Rectum; 2007 Mar; 50(3):331-6. PubMed ID: 17252288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy.
    Esaki M; Matsumoto T; Nakamura S; Yada S; Fujisawa K; Jo Y; Iida M
    Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S68-74. PubMed ID: 17106818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.